RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cancer; Fallopian Tube; Epithelial Ovarian Interventions: Drug: RC88 Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
The PIPAC PET Pilot Study, OPC-7
Conditions: Peritoneal Cancer; Peritoneal Metastases; Peritoneal Carcinomatosis; Abdominal Cancer Interventions: Other: scan Sponsors: Odense University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Role of PET/CT in Peritoneal Deposits Assessment
Conditions: Peritoneal Metastases Interventions: Device: PET/CT Sponsors: Aya Khaled Mahmoud Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)
Conditions: Peritoneal Metastases From Colorectal Cancer Interventions: Procedure: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Drug: KAND567; Drug: Carboplatin Sponsors: Kancera AB; Nordic Society of Gynaecological Oncology - Clinical Trials Unit Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
Conditions: Ovarian Cancer; High Grade Serous Adenocarcinoma of Ovary; High Grade Endometrioid Ovarian Cancer; Primary Peritoneal Cancer; Fallopian-tube Cancer Interventions: Drug: Fluzoparib Capsules; Drug: Bevacizumab Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
Conditions: Cancer; Peritoneal Carcinomatosis Interventions: Diagnostic Test: FAPI PET/CT Sponsors: Jules Bordet Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)
Condition: Peritoneal Metastases From Colorectal Cancer Intervention: Procedure: Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC) Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)
Conditions: Peritoneal Metastases From Colorectal Cancer Interventions: Procedure: Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC) Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Condition: Epithelial Ovarian Cancer Intervention: Drug: Envafolimab Sponsor: Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials
